High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
The T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies.
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-31229-z |
_version_ | 1811328520960344064 |
---|---|
author | A.-M. Globig A. V. Hipp P. Otto-Mora M. Heeg L. S. Mayer S. Ehl H. Schwacha M. Bewtra V. Tomov R. Thimme P. Hasselblatt B. Bengsch |
author_facet | A.-M. Globig A. V. Hipp P. Otto-Mora M. Heeg L. S. Mayer S. Ehl H. Schwacha M. Bewtra V. Tomov R. Thimme P. Hasselblatt B. Bengsch |
author_sort | A.-M. Globig |
collection | DOAJ |
description | The T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies. |
first_indexed | 2024-04-13T15:27:35Z |
format | Article |
id | doaj.art-4b2e3af4e8874ad2adc7e59066cb9554 |
institution | Directory Open Access Journal |
issn | 2041-1723 |
language | English |
last_indexed | 2024-04-13T15:27:35Z |
publishDate | 2022-06-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Nature Communications |
spelling | doaj.art-4b2e3af4e8874ad2adc7e59066cb95542022-12-22T02:41:28ZengNature PortfolioNature Communications2041-17232022-06-0113111510.1038/s41467-022-31229-zHigh-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signatureA.-M. Globig0A. V. Hipp1P. Otto-Mora2M. Heeg3L. S. Mayer4S. Ehl5H. Schwacha6M. Bewtra7V. Tomov8R. Thimme9P. Hasselblatt10B. Bengsch11Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of MedicineDepartment of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of MedicineDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgDepartment of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, University Medical Center FreiburgThe T cell compartment in patients with Crohn's disease is dysregulated. Here the authors use cytometric profiling to reveal an enrichment of distinct Tc17 cells during active Crohn's disease and may suggest CD6 as a potential target for therapeutic studies.https://doi.org/10.1038/s41467-022-31229-z |
spellingShingle | A.-M. Globig A. V. Hipp P. Otto-Mora M. Heeg L. S. Mayer S. Ehl H. Schwacha M. Bewtra V. Tomov R. Thimme P. Hasselblatt B. Bengsch High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature Nature Communications |
title | High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature |
title_full | High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature |
title_fullStr | High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature |
title_full_unstemmed | High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature |
title_short | High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature |
title_sort | high dimensional profiling reveals tc17 cell enrichment in active crohn s disease and identifies a potentially targetable signature |
url | https://doi.org/10.1038/s41467-022-31229-z |
work_keys_str_mv | AT amglobig highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT avhipp highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT pottomora highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT mheeg highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT lsmayer highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT sehl highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT hschwacha highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT mbewtra highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT vtomov highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT rthimme highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT phasselblatt highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature AT bbengsch highdimensionalprofilingrevealstc17cellenrichmentinactivecrohnsdiseaseandidentifiesapotentiallytargetablesignature |